Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study

Clinical trial NCT01679964 · COMPLETED

Trial details

NCT number: NCT01679964
Sponsor: Lin, Hsi-Hsun, M.D.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Infection Adverse Drug Reaction Quality of Life

Start date: 2012-07-01
Primary completion: 2015-02-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.